ARCOSA INC (ACA) Fundamental Analysis & Valuation

NYSE:ACA • US0396531008

Current stock price

110.79 USD
-0.47 (-0.42%)
At close:
110.79 USD
0 (0%)
After Hours:

This ACA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ACA Profitability Analysis

1.1 Basic Checks

  • In the past year ACA was profitable.
  • In the past year ACA had a positive cash flow from operations.
  • In the past 5 years ACA has always been profitable.
  • In the past 5 years ACA always reported a positive cash flow from operatings.
ACA Yearly Net Income VS EBIT VS OCF VS FCFACA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

1.2 Ratios

  • The Return On Assets of ACA (4.17%) is comparable to the rest of the industry.
  • ACA has a Return On Equity of 7.88%. This is comparable to the rest of the industry: ACA outperforms 49.09% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.80%, ACA is in line with its industry, outperforming 45.45% of the companies in the same industry.
  • ACA had an Average Return On Invested Capital over the past 3 years of 4.62%. This is significantly below the industry average of 13.89%.
  • The last Return On Invested Capital (5.80%) for ACA is above the 3 year average (4.62%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.17%
ROE 7.88%
ROIC 5.8%
ROA(3y)3.51%
ROA(5y)4%
ROE(3y)6.18%
ROE(5y)6.66%
ROIC(3y)4.62%
ROIC(5y)4.24%
ACA Yearly ROA, ROE, ROICACA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 7.22%, ACA is in the better half of the industry, outperforming 74.55% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ACA has grown nicely.
  • With a decent Operating Margin value of 11.37%, ACA is doing good in the industry, outperforming 78.18% of the companies in the same industry.
  • ACA's Operating Margin has improved in the last couple of years.
  • ACA's Gross Margin of 22.45% is fine compared to the rest of the industry. ACA outperforms 70.91% of its industry peers.
  • In the last couple of years the Gross Margin of ACA has grown nicely.
Industry RankSector Rank
OM 11.37%
PM (TTM) 7.22%
GM 22.45%
OM growth 3Y16.52%
OM growth 5Y6.57%
PM growth 3Y-12.89%
PM growth 5Y5.71%
GM growth 3Y5.99%
GM growth 5Y2.61%
ACA Yearly Profit, Operating, Gross MarginsACA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ACA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACA is destroying value.
  • The number of shares outstanding for ACA has been increased compared to 1 year ago.
  • The number of shares outstanding for ACA has been increased compared to 5 years ago.
  • ACA has a better debt/assets ratio than last year.
ACA Yearly Shares OutstandingACA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
ACA Yearly Total Debt VS Total AssetsACA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.61 indicates that ACA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.61, ACA is in line with its industry, outperforming 41.82% of the companies in the same industry.
  • ACA has a debt to FCF ratio of 8.68. This is a slightly negative value and a sign of low solvency as ACA would need 8.68 years to pay back of all of its debts.
  • ACA has a Debt to FCF ratio (8.68) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.57 indicates that ACA is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.57, ACA perfoms like the industry average, outperforming 56.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 8.68
Altman-Z 2.61
ROIC/WACC0.59
WACC9.86%
ACA Yearly LT Debt VS Equity VS FCFACA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • A Current Ratio of 2.20 indicates that ACA has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.20, ACA belongs to the top of the industry, outperforming 85.45% of the companies in the same industry.
  • A Quick Ratio of 1.35 indicates that ACA should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.35, ACA is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.35
ACA Yearly Current Assets VS Current LiabilitesACA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ACA Growth Analysis

3.1 Past

  • ACA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.50%, which is quite impressive.
  • The Earnings Per Share has been growing by 12.78% on average over the past years. This is quite good.
  • Looking at the last year, ACA shows a quite strong growth in Revenue. The Revenue has grown by 12.20% in the last year.
  • ACA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.30% yearly.
EPS 1Y (TTM)48.5%
EPS 3Y26.66%
EPS 5Y12.78%
EPS Q2Q%150%
Revenue 1Y (TTM)12.2%
Revenue growth 3Y8.74%
Revenue growth 5Y8.3%
Sales Q2Q%7.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.28% on average over the next years. This is quite good.
  • ACA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.28% yearly.
EPS Next Y8.02%
EPS Next 2Y12.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.91%
Revenue Next 2Y5.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACA Yearly Revenue VS EstimatesACA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
ACA Yearly EPS VS EstimatesACA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

5

4. ACA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 24.79, ACA is valued on the expensive side.
  • ACA's Price/Earnings ratio is a bit cheaper when compared to the industry. ACA is cheaper than 78.18% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.53, ACA is valued at the same level.
  • ACA is valuated rather expensively with a Price/Forward Earnings ratio of 22.94.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ACA indicates a somewhat cheap valuation: ACA is cheaper than 78.18% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of ACA to the average of the S&P500 Index (37.95), we can say ACA is valued slightly cheaper.
Industry RankSector Rank
PE 24.79
Fwd PE 22.94
ACA Price Earnings VS Forward Price EarningsACA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ACA is valued cheaper than 83.64% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ACA is valued a bit cheaper than 61.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF 31
EV/EBITDA 12.29
ACA Per share dataACA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACA does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of ACA may justify a higher PE ratio.
  • A more expensive valuation may be justified as ACA's earnings are expected to grow with 12.28% in the coming years.
PEG (NY)3.09
PEG (5Y)1.94
EPS Next 2Y12.28%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ACA Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.18%, ACA is not a good candidate for dividend investing.
  • ACA's Dividend Yield is rather good when compared to the industry average which is at 0.14. ACA pays more dividend than 81.82% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ACA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

  • The dividend of ACA has a limited annual growth rate of 0.14%.
  • ACA has been paying a dividend for over 5 years, so it has already some track record.
  • ACA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)0.14%
Div Incr Years0
Div Non Decr Years6
ACA Yearly Dividends per shareACA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • ACA pays out 4.81% of its income as dividend. This is a sustainable payout ratio.
  • ACA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP4.81%
EPS Next 2Y12.28%
EPS Next 3YN/A
ACA Yearly Income VS Free CF VS DividendACA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
ACA Dividend Payout.ACA Dividend Payout, showing the Payout Ratio.ACA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ACA Fundamentals: All Metrics, Ratios and Statistics

ARCOSA INC

NYSE:ACA (4/16/2026, 6:05:35 PM)

After market: 110.79 0 (0%)

110.79

-0.47 (-0.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-26
Earnings (Next)04-23
Inst Owners94.28%
Inst Owner Change-0.02%
Ins Owners1.79%
Ins Owner Change8.11%
Market Cap5.44B
Revenue(TTM)2.88B
Net Income(TTM)208.10M
Analysts84
Price Target130.39 (17.69%)
Short Float %2.4%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend0.2
Dividend Growth(5Y)0.14%
DP4.81%
Div Incr Years0
Div Non Decr Years6
Ex-Date04-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.92%
Min EPS beat(2)15.61%
Max EPS beat(2)24.24%
EPS beat(4)4
Avg EPS beat(4)54.93%
Min EPS beat(4)15.61%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)28.84%
EPS beat(12)11
Avg EPS beat(12)33.04%
EPS beat(16)15
Avg EPS beat(16)36.75%
Revenue beat(2)1
Avg Revenue beat(2)-0.02%
Min Revenue beat(2)-1.23%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-0.48%
Min Revenue beat(4)-3.72%
Max Revenue beat(4)1.83%
Revenue beat(8)3
Avg Revenue beat(8)-1.48%
Revenue beat(12)6
Avg Revenue beat(12)0.12%
Revenue beat(16)10
Avg Revenue beat(16)1.69%
PT rev (1m)3.76%
PT rev (3m)6.71%
EPS NQ rev (1m)-0.62%
EPS NQ rev (3m)-18.99%
EPS NY rev (1m)-0.95%
EPS NY rev (3m)-0.95%
Revenue NQ rev (1m)0.86%
Revenue NQ rev (3m)-2.92%
Revenue NY rev (1m)-1.21%
Revenue NY rev (3m)-1.91%
Valuation
Industry RankSector Rank
PE 24.79
Fwd PE 22.94
P/S 1.89
P/FCF 31
P/OCF 15.95
P/B 2.06
P/tB 5.54
EV/EBITDA 12.29
EPS(TTM)4.47
EY4.03%
EPS(NY)4.83
Fwd EY4.36%
FCF(TTM)3.57
FCFY3.23%
OCF(TTM)6.95
OCFY6.27%
SpS58.73
BVpS53.8
TBVpS19.99
PEG (NY)3.09
PEG (5Y)1.94
Graham Number73.5565 (-33.61%)
Profitability
Industry RankSector Rank
ROA 4.17%
ROE 7.88%
ROCE 7.32%
ROIC 5.8%
ROICexc 6.09%
ROICexgc 9.96%
OM 11.37%
PM (TTM) 7.22%
GM 22.45%
FCFM 6.09%
ROA(3y)3.51%
ROA(5y)4%
ROE(3y)6.18%
ROE(5y)6.66%
ROIC(3y)4.62%
ROIC(5y)4.24%
ROICexc(3y)4.82%
ROICexc(5y)4.43%
ROICexgc(3y)8.06%
ROICexgc(5y)7.51%
ROCE(3y)5.83%
ROCE(5y)5.36%
ROICexgc growth 3Y7.62%
ROICexgc growth 5Y-0.63%
ROICexc growth 3Y10.26%
ROICexc growth 5Y1.46%
OM growth 3Y16.52%
OM growth 5Y6.57%
PM growth 3Y-12.89%
PM growth 5Y5.71%
GM growth 3Y5.99%
GM growth 5Y2.61%
F-Score9
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 8.68
Debt/EBITDA 2.75
Cap/Depr 74.26%
Cap/Sales 5.74%
Interest Coverage 3.18
Cash Conversion 61.92%
Profit Quality 84.33%
Current Ratio 2.2
Quick Ratio 1.35
Altman-Z 2.61
F-Score9
WACC9.86%
ROIC/WACC0.59
Cap/Depr(3y)99.71%
Cap/Depr(5y)89.53%
Cap/Sales(3y)7.31%
Cap/Sales(5y)6.45%
Profit Quality(3y)151.62%
Profit Quality(5y)117.46%
High Growth Momentum
Growth
EPS 1Y (TTM)48.5%
EPS 3Y26.66%
EPS 5Y12.78%
EPS Q2Q%150%
EPS Next Y8.02%
EPS Next 2Y12.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.2%
Revenue growth 3Y8.74%
Revenue growth 5Y8.3%
Sales Q2Q%7.58%
Revenue Next Year3.91%
Revenue Next 2Y5.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y67.98%
EBIT growth 3Y26.7%
EBIT growth 5Y15.41%
EBIT Next Year75.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.8%
FCF growth 3Y69.09%
FCF growth 5Y-0.26%
OCF growth 1Y-32.05%
OCF growth 3Y25.08%
OCF growth 5Y5.59%

ARCOSA INC / ACA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ARCOSA INC?

ChartMill assigns a fundamental rating of 6 / 10 to ACA.


Can you provide the valuation status for ARCOSA INC?

ChartMill assigns a valuation rating of 5 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.


What is the profitability of ACA stock?

ARCOSA INC (ACA) has a profitability rating of 7 / 10.


What is the expected EPS growth for ARCOSA INC (ACA) stock?

The Earnings per Share (EPS) of ARCOSA INC (ACA) is expected to grow by 8.02% in the next year.


Can you provide the dividend sustainability for ACA stock?

The dividend rating of ARCOSA INC (ACA) is 5 / 10 and the dividend payout ratio is 4.81%.